UBS Group’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $365K | Sell |
94,679
-174,114
| -65% | -$685K | ﹤0.01% | 6294 |
|
|
2025
Q4 | $1.06M | Sell |
268,793
-204,307
| -43% | -$904K | ﹤0.01% | 5517 |
|
|
2025
Q3 | $2.21M | Buy |
473,100
+17,558
| +4% | +$63.5K | ﹤0.01% | 4844 |
|
|
2025
Q2 | $1.42M | Buy |
455,542
+99,610
| +28% | +$321K | ﹤0.01% | 5139 |
|
|
2025
Q1 | $1.2M | Buy |
355,932
+156,622
| +79% | +$732K | ﹤0.01% | 5125 |
|
|
2024
Q4 | $1.13M | Buy |
199,310
+175,047
| +721% | +$1.13M | ﹤0.01% | 5209 |
|
|
2024
Q3 | $142K | Sell |
24,263
-34,229
| -59% | -$249K | ﹤0.01% | 6106 |
|
|
2024
Q2 | $463K | Sell |
58,492
-45,792
| -44% | -$384K | ﹤0.01% | 5062 |
|
|
2024
Q1 | $971K | Buy |
104,284
+71,590
| +219% | +$604K | ﹤0.01% | 4617 |
|
|
2023
Q4 | $276K | Buy |
32,694
+18,535
| +131% | +$134K | ﹤0.01% | 5562 |
|
|
2023
Q3 | $110K | Sell |
14,159
-11,678
| -45% | -$107K | ﹤0.01% | 5772 |
|
|
2023
Q2 | $296K | Buy |
25,837
+20,785
| +411% | +$215K | ﹤0.01% | 5215 |
|
|
2023
Q1 | $39K | Buy |
+5,052
| New | +$40.2K | ﹤0.01% | 6617 |
|
|
2022
Q4 | – | Sell |
-2,703
| Closed | -$16K | – | 11184 |
|
|
2022
Q3 | $16K | Buy |
2,703
+2,492
| +1,181% | +$16K | ﹤0.01% | 7715 |
|
|
2022
Q2 | $1K | Sell |
211
-3,914
| -95% | -$26.4K | ﹤0.01% | 9977 |
|
|
2022
Q1 | $31K | Sell |
4,125
-2,528
| -38% | -$11.3K | ﹤0.01% | 6969 |
|
|
2021
Q4 | $18K | Sell |
6,653
-181,868
| -96% | -$621K | ﹤0.01% | 7994 |
|
|
2021
Q3 | $496K | Buy |
188,521
+42,422
| +29% | +$138K | ﹤0.01% | 4743 |
|
|
2021
Q2 | $603K | Buy |
146,099
+3,614
| +3% | +$16.4K | ﹤0.01% | 4584 |
|
|
2021
Q1 | $672K | Buy |
142,485
+111,531
| +360% | +$760K | ﹤0.01% | 4628 |
|
|
2020
Q4 | $221K | Buy |
30,954
+29,284
| +1,754% | +$281K | ﹤0.01% | 5181 |
|
|
2020
Q3 | $18K | Sell |
1,670
-3,820
| -70% | -$44.8K | ﹤0.01% | 6406 |
|
|
2020
Q2 | $69K | Buy |
5,490
+4,290
| +358% | +$49.9K | ﹤0.01% | 5604 |
|
|
2020
Q1 | $11K | Sell |
1,200
-9,201
| -88% | -$106K | ﹤0.01% | 6883 |
|
|
2019
Q4 | $145K | Sell |
10,401
-86,264
| -89% | -$1.25M | ﹤0.01% | 5804 |
|
|
2019
Q3 | $1.66M | Buy |
96,665
+73,173
| +311% | +$1.54M | ﹤0.01% | 3485 |
|
|
2019
Q2 | $640K | Buy |
23,492
+19,763
| +530% | +$452K | ﹤0.01% | 4110 |
|
|
2019
Q1 | $71K | Buy |
3,729
+1,721
| +86% | +$22.4K | ﹤0.01% | 5314 |
|
|
2018
Q4 | $19K | Buy |
2,008
+1,708
| +569% | +$21.9K | ﹤0.01% | 6842 |
|
|
2018
Q3 | $6K | Sell |
300
-200
| -40% | -$3.84K | ﹤0.01% | 7423 |
|
|
2018
Q2 | $10K | Sell |
500
-35,875
| -99% | -$709K | ﹤0.01% | 7146 |
|
|
2018
Q1 | $684K | Buy |
+36,375
| New | +$786K | ﹤0.01% | 3995 |
|
|
2017
Q4 | – | Sell |
-771
| Closed | -$16K | – | 8127 |
|
|
2017
Q3 | $16K | Buy |
+771
| New | +$8.7K | ﹤0.01% | 6611 |
|
|
2017
Q2 | – | Sell |
-745
| Closed | -$10K | – | 8014 |
|
|
2017
Q1 | $10K | Sell |
745
-2,273
| -75% | -$27.6K | ﹤0.01% | 6624 |
|
|
2016
Q4 | $38K | Buy |
3,018
+1,754
| +139% | +$22.5K | ﹤0.01% | 6042 |
|
|
2016
Q3 | $15K | Buy |
+1,264
| New | +$17.1K | ﹤0.01% | 6529 |
|
|
2016
Q2 | – | Sell |
-1,390
| Closed | -$12K | – | 8004 |
|
|
2016
Q1 | $12K | Buy |
1,390
+39
| +3% | +$442 | ﹤0.01% | 6548 |
|
|
2015
Q4 | $30K | Buy |
+1,351
| New | +$31.1K | ﹤0.01% | 6331 |
|
Other funds holding VYGR
AC
VPC
VCM
OM
EAM
